Unicycive Therapeutics Announces Publication of Positive

Newly Assigned USAN Name, Oxylanthanum Carbonate, replaces Lanthanum Dioxycarbonate...

Related Keywords

United States ,American ,Stuart Sprague ,Shalabh Gupta ,University Of Chicago Pritzker School Medicine ,Northshore University Healthsystem ,Company Or Unicycive ,Nasdaq ,Shire International Licensing ,Division Of Nephrology ,Reason Research ,Unicycive Therapeutics Inc ,Exchange Commission ,American Journal ,United States Adopted Name ,Phosphate Binding Capacity ,Oxylanthanum Carbonate ,Low Medication Volume ,Commercially Available Phosphate Binders ,Chief Emeritus ,Clinical Professor ,Chicago Pritzker School ,End Stage Renal Disease ,Private Securities Litigation Reform Act ,Risk Factor ,Annual Report ,Unicycive Therapeutics ,Nasdaq Uncy ,Nc ,Hronickidneydisease ,